Guided Therapeutics, Inc. GTHP
Set alert
0.13 USD -0.02 -13.33%
As of Nov 2, 12:20 PM ET
0.13 Day range 0.1301
0.13 52-week range 0.54
- YTD
- -75.93%
- 1 year
- -51.85%
- Open
- 0.1301
- Prev close
- 0.15
- Mkt cap
- 12.55M
- Vol
- 211.00K
- Avg vol
- 26.92K
- EPS
- -0.04
- P/E
- 0.00
More statistics
- Low
- 0.13
- High
- 0.1301
2Y chart
Events in this range
- Nov 14, 2024Earnings: -0.01; estimate 0; surprise —%
Signals (116)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
Newest 20 of 116.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.01 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.01 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 18, 2021 | Jun 1, 2021 | 0.00 | -0.09 | — | — |
| Jul 7, 2020 | Mar 1, 2020 | 0.00 | 0.04 | — | — |
News
- Guided Therapeutics Inc. (OTCMKTS:GTHP) Shares Shorted: Short Interest Up 55.0% in September
- Guided Therapeutics Reaches Collaborative Agreement with Türkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer
- Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
- Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
- Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
- Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
- Haemonetics (NYSE:HAE) vs. Guided Therapeutics (OTCMKTS:GTHP) Head to Head Review
- Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
- Guided Therapeutics (OTCMKTS:GTHP) Shares Down 12.7% – Time to Sell?
- Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
Your note
Sign in to keep a note on GTHP — it syncs with the Stock Master app.